Michelle and David. Thank you for this enlightening conversation about the limited evidence we are working with when it comes to Octreotide and other Palliative Management of malignant bowel obstructions. We appreciate your time, your papers from 2015 and 2024, and your expertise.
Michelle and David. Thank you for this enlightening conversation about the limited evidence we are working with when it comes to Octreotide and other Palliative Management of malignant bowel obstructions. We appreciate your time, your papers from 2015 and 2024, and your expertise.